Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
1.
Anaesthesia ; 66(10): 913-8, 2011 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-21851342

RESUMO

In current practice, the length of epidural catheter that should be left in the epidural space is not standardised for effective postoperative analgesia. This prospective, randomised, double-blinded study aimed to determine the most appropriate length of epidural catheter that should be inserted into the epidural space for postoperative analgesia. We recruited 102 women and assigned them into three study groups (3, 5 and 7 cm insertion). An epidural catheter was inserted and epidurography was performed. Postoperatively, mean pain scores, motor and sensory levels, and any complications associated with the epidural catheter were recorded. No statistically significant difference for mean postoperative pain score was found at all study timings. Motor and sensory blockade was also statistically insignificant. Unilateral sensory analgesia developed in one patient in the 7 cm group and epidural catheter dislodgement was observed in four patients in the 3 cm group. In order to minimise catheter-related complications for postoperative analgesia, the most appropriate length that an epidural catheter should be left in the epidural space is 5 cm. You can respond to this article at http://www.anaesthesiacorrespondence.com.


Assuntos
Analgesia Epidural/métodos , Espaço Epidural/anatomia & histologia , Dor Pós-Operatória/tratamento farmacológico , Adulto , Analgesia Epidural/efeitos adversos , Analgesia Epidural/instrumentação , Anestésicos Locais/efeitos adversos , Catéteres , Método Duplo-Cego , Feminino , Humanos , Histerectomia , Pessoa de Meia-Idade , Monitorização Intraoperatória , Agulhas , Medição da Dor , Satisfação do Paciente , Medicação Pré-Anestésica
2.
Free Radic Biol Med ; 20(3): 319-29, 1996.
Artigo em Inglês | MEDLINE | ID: mdl-8720902

RESUMO

A new method was developed that reduces the intracellular iron content of cells grown in serum-containing culture without involving the significant uptake of iron-chelating agents into cells. Negatively charged bathophenanthrolinedisulfonate (BPS), together with ascorbate, caused cells to lose much of their cellular iron without causing much depression in HL-60 or H9c2 (2-1) cell proliferation over a 48-h period. When added to serum supplemented RPMI-1640 culture media, BPS and ascorbate efficiently reduced and competed for iron in Fe(III) transferrin to form Fe(II)(BPS)3. The reaction also occurred with purified human iron-transferrin. When cells were incubated with growth medium containing serum that had been treated with BPS and ascorbate for 24 h, little or no BPS2- or Fe(II)(BPS)(4-)3 entered the cells, according to direct measurements and in agreement with the highly unfavorable 1-octanol/water partition coefficients for these molecules. However, iron was mobilized out of both cell types. After 24 h incubation of cells in this medium, there was no change in the activities of catalase and superoxide dismutase, or in the concentration of glutathione. Glutathione peroxidase was elevated 9%. Using HL-60 and H9c2 (2-1) cells made iron deficient with BPS and ascorbate, HL-60 cells grown in defined-growth media in the absence of iron-pyridoxal isonicotinoyl hydrazone, or Euglena gracilis cells maintained in a defined medium that was rigorously depleted of iron, it was shown that the cytotoxicity of adriamycin is markedly dependent on the presence of iron in each type of cell. Similar results were obtained when HL-60 cells were grown in RPMI-1640 culture medium and serum that had been incubated for 24 h in BPS and ascorbate and then chromatographed over a Bio-Rad desalting column to remove small molecules including BPS, ascorbate, and Fe(II)(BPS)3.


Assuntos
Ácido Ascórbico/farmacologia , Quelantes/farmacologia , Doxorrubicina/toxicidade , Euglena gracilis/metabolismo , Ferro/metabolismo , Fenantrolinas/farmacologia , Animais , Catalase/metabolismo , Sobrevivência Celular/efeitos dos fármacos , Células Cultivadas , Euglena gracilis/efeitos dos fármacos , Glutationa/análogos & derivados , Glutationa/metabolismo , Dissulfeto de Glutationa , Glutationa Peroxidase/metabolismo , Células HL-60 , Humanos , Quelantes de Ferro/farmacologia , Cinética , Miocárdio/metabolismo , Ratos , Superóxido Dismutase/metabolismo
3.
J Pak Med Assoc ; 53(2): 68-72, 2003 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-12705488

RESUMO

OBJECTIVE: To evaluate the effectiveness of acupressure applied at meridian P6 point for prevention of nausea and vomiting in patients undergoing laparoscopic cholecystectomy. METHODOLOGY: A randomized double blind study was performed in 50 ASA I and II patients scheduled for laparoscopic cholecystectomy. Patients were divided into two groups; control and placebo. In the control group acupressure was applied at P6 point half an hour before surgery while in the placebo group the acupressure band was tied on meridian P6 point but the plastic bead was placed on the dosum of right forearm away from meridian P6 point. Patients were assessed for nausea and vomiting for six hours after surgery. Anaesthetic technique and postoperative analgesia were standardized for all patients. RESULTS: Results showed that the incidence of postoperative nausea and vomiting was 36% in the treatment group and 40% in placebo group, which is statistically insignificant. CONCLUSION: Application of acupressure at P6 point half an hour before induction of anaesthesia does not significantly alter the incidence of postoperative nausea and/or vomiting within 6 hours after surgery.


Assuntos
Acupressão , Colecistectomia Laparoscópica , Náusea e Vômito Pós-Operatórios/prevenção & controle , Adulto , Análise de Variância , Distribuição de Qui-Quadrado , Método Duplo-Cego , Feminino , Humanos , Incidência , Masculino , Náusea e Vômito Pós-Operatórios/epidemiologia , Estudos Prospectivos , Resultado do Tratamento
4.
J Pak Med Assoc ; 54(6): 319-22, 2004 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-15366798

RESUMO

OBJECTIVE: To compare the analgesic efficacy and side effects of ketorolac with pethidine in a day care procedure. STUDY DESIGN: Single dose, double blind, case matched study. METHODS: Sixty patients were divided into group A and group B, who received either ketorolac 30 mg or Pethidine 0.8 mg/kg ( both IN ) respectively at the time of induction of general anaesthesia. Patients were assessed in recovery room for pain according to visual analogue scale and any side effects. Amount of rescue analgesia required by both groups were also recorded. Odds Ratio and and Chi Square test were used for statistical analysis. RESULTS: Statistical analysis showed no significant differences between these two drugs at any time interval, however a significantly decreased incidence of nausea and drowsiness was found in ketorolac group. CONCLUSION: Ketorolac 30 mg intravenously provides similar analgesic effects as Pethidine with much less incidence of nausea and drowsiness.


Assuntos
Anti-Inflamatórios não Esteroides/uso terapêutico , Cetorolaco/uso terapêutico , Dor Pós-Operatória/tratamento farmacológico , Adulto , Anti-Inflamatórios não Esteroides/administração & dosagem , Estudos de Casos e Controles , Relação Dose-Resposta a Droga , Método Duplo-Cego , Feminino , Humanos , Cetorolaco/administração & dosagem , Masculino , Dor Pós-Operatória/etiologia , Fatores de Tempo , Extração Dentária/efeitos adversos , Resultado do Tratamento
5.
J Pak Med Assoc ; 52(2): 66-9, 2002 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-12073713

RESUMO

OBJECTIVE: To assess whether a unilateral spinal anaesthesia using 0.5% hyperbaric Bupivacaine will restrict the sympathetic block to avoid the undesired cardio vascular effects. METHODOLOGY: In this study 40 ASA III and IV patients aged between 60-90 years undergoing unilateral lower limb surgery were included. All patients received unilateral spinal anaesthesia using hyperbaric 0.5% Bupivacaine (1.1-1.8 ml according to patient's height). Patients were placed in the lateral position with operated side down and kept in this position for 10 minutes. Motor and sensory levels were assessed, and haemodynamic alterations were monitored for 30 minutes after initiation of spinal anaesthesia. RESULTS: Unilateral spinal anaesthesia is very effective in restricting the sympathetic block as all high risk patients showed minimal haemodynamic changes following the technique. CONCLUSION: Unilateral spinal anaesthesia is effective in restricting the sympathetic block in high risk patients.


Assuntos
Raquianestesia/métodos , Anestésicos Locais/farmacologia , Bupivacaína/farmacologia , Hemodinâmica/efeitos dos fármacos , Idoso , Idoso de 80 Anos ou mais , Raquianestesia/efeitos adversos , Bloqueio Nervoso Autônomo , Pressão Sanguínea/efeitos dos fármacos , Feminino , Humanos , Hipotensão/etiologia , Masculino , Pessoa de Meia-Idade , Neurônios Motores/efeitos dos fármacos , Neurônios Aferentes/efeitos dos fármacos , Fatores de Risco , Fatores de Tempo
7.
Paediatr Anaesth ; 6(3): 239-42, 1996.
Artigo em Inglês | MEDLINE | ID: mdl-8732618

RESUMO

This is a case report of an 18-month-old 10 kg child who presented for emergency repair of a recurrent diaphragmatic hernia with a history of craniofacial dystosis and was given a caudal block postoperatively with a combination of 4 ml of 0.5% bupivacaine and 2.5 micrograms.kg-1 buprenorphine made up to a total volume of 10 ml. An inadvertent dural puncture occurred resulting in total spinal block which was managed symptomatically. Block regression started one h later when the respiratory movements became noticeable. Eye opening and hand movements returned 3 h later. The patient's exposure to a large intrathecal dose of buprenorphine did not lead to prolonged respiratory depression. The possibility of a midbrain insult due to a sudden rise in intracranial pressure is also discussed.


Assuntos
Analgésicos Opioides/administração & dosagem , Raquianestesia , Anestésicos Locais/administração & dosagem , Bupivacaína/administração & dosagem , Buprenorfina/administração & dosagem , Bloqueio Nervoso , Analgesia Epidural/efeitos adversos , Analgésicos Opioides/efeitos adversos , Anestésicos Locais/efeitos adversos , Bupivacaína/efeitos adversos , Buprenorfina/efeitos adversos , Dura-Máter , Hérnia Diafragmática/cirurgia , Humanos , Lactente , Injeções Espinhais/efeitos adversos , Masculino , Bloqueio Nervoso/efeitos adversos , Punções/efeitos adversos , Recidiva , Medula Espinal/efeitos dos fármacos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA